<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F1494C6F-6E63-47EF-9F48-7FF52EB02450"><gtr:id>F1494C6F-6E63-47EF-9F48-7FF52EB02450</gtr:id><gtr:name>Autolus Limited</gtr:name><gtr:address><gtr:line1>c/o Syncona Partners LLP
215 Euston Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F1494C6F-6E63-47EF-9F48-7FF52EB02450" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F1494C6F-6E63-47EF-9F48-7FF52EB02450</gtr:id><gtr:name>Autolus Limited</gtr:name><gtr:address><gtr:line1>c/o Syncona Partners LLP
215 Euston Road</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>1151331.0</gtr:offerGrant><gtr:projectCost>1644759.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=102571"><gtr:id>8DD53465-0849-41CC-B91D-6AF9FA746AE1</gtr:id><gtr:title>CAR Therapy for T Cell Malignancies</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>102571</gtr:grantReference><gtr:abstractText>T-cells are immune cells in our bodies whose function is to &amp;quot;seek and destroy&amp;quot; cells which are infected by

viruses. Since T-cells actively move around our bodies looking for infected cells, medical science has long tried

to make these T-cells attack cancer cells. Because cancer cells usually come from normal cells in our bodies

without virus infections, T-cells don't normally attack them. By taking T-cells from a blood sample and &amp;quot;re-

programming&amp;quot; them using genetic engineering, medical science has found a way of using T-cells to attack

cancer. These engineered T-cells are called &amp;quot;CAR T-cells&amp;quot; and they can be given back to the patient as a drip.

Once back in the patient, they &amp;quot;seek and destroy&amp;quot; cancer cells as if they were virus-infected cells. CAR T-cells

seem to be a very effective new form of cancer treatment. Cancers can come from any cells in our bodies. Even

T-cells can become cancer cells and some of these cancers are called T-cell lymphomas. This project deals with

the particular problem of CAR T-cells attacking T-cell lymphomas. Scientists working on this project have found

a way of making CAR T-cells that attack the cancerous T-cells but leave plenty of normal healthy T-cells alone.</gtr:abstractText><gtr:fund><gtr:end>2018-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1682111</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">102571</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>